Rating: Sell

Executive Summary: Keputusan akhir untuk SRSN.JK adalah Sell: kurangi eksposur sekarang, jangan inisiasi posisi baru di Rp115, dan jangan averaging down. Jika pemanggil belum memegang SRSN.JK, alokasi tetap 0%; jika masih memegang posisi seukuran alokasi normal, pangkas bertahap dengan limit order 2–3 tranche menuju residual maksimum 0,25–0,35x alokasi standar (batas keras 0,4x), memanfaatkan likuiditas di Rp118–126 tetapi tanpa menggantungkan seluruh exit pada rebound tersebut. Untuk residual, hard stop adalah penutupan harian di bawah Rp106 (close-only, karena hanya ~0,7 ATR dengan ATR Rp11,68), dengan soft de-risking jika close di bawah SMA50 Rp110,60. Horizon 1–3 bulan, sampai laporan Q3 2026 atau data arus kas operasi tersedia.

Investment Thesis: Ketiga risk analyst — Agresif, Konservatif, dan Netral — sampai pada arah yang sama untuk SRSN.JK: Sell/Underweight, bukan Hold dan bukan fresh long. Konflik di antara mereka hanya soal kecepatan eksekusi dan besar residual, bukan soal arah, sehingga tidak ada dasar untuk memilih Hold.

Yang memutuskan adalah kualitas tape. Struktur harian SRSN.JK rusak secara terukur: lower highs 150 → 132 → 126, gap down 16 Oktober dari close 124 ke close 106, bounce 22 Oktober gagal berurutan 132 → 130 → 129 → 122 → 115, dan close terakhir di Rp115 berada di bawah EMA10 Rp120,26 serta SMA20 Rp126,10. MACD histogram −1,98 setelah recovery macet di 1,76 adalah re-cross kontinuasi, bukan bottom; RSI 47,18 bukan oversold sehingga premis "oversold bounce" gugur. Volume 144 juta versus rata-rata 20 hari ~256 juta (0,6x) menunjukkan penurunan dengan volume mengecil — indifference, bukan seller climax yang layak dibeli.

Kedua, jangkar tesis beli tidak terverifikasi. Angka H1 2026 memang terlihat kuat (revenue Rp318,08 miliar, gross profit Rp91,84 miliar, operating profit Rp53,34 miliar, net profit Rp43,16 miliar; margin 28,9% gross dan 16,8% operating), tetapi tidak ada operating cash flow, balance sheet, net debt, working capital, maupun perbandingan YoY/seasonality/Q3. EPS annualized Rp14,3 dan P/E ~8x karena itu adalah hipotesis bahwa spread ethanol/molasses bertahan, bukan margin of safety. Bahkan klaim "low leverage" yang dipakai kubu konservatif sebagai penopang tidak terverifikasi karena balance sheet hanya stub — jadi argumen itu tidak bisa dipakai menahan eksposur penuh.

Ketiga, katalis insider sudah basi. 14 pembelian Mulyadi Utomo Budhi Moeljono di Rp60–67 terjadi Mei–Juni 2026, kini 70–85% di bawah harga Rp115, tanpa pembelian baru sekitar empat bulan, sementara Ludijanto Setijo keluar penuh di Rp67–68. Itu bukti insentif di Rp60–67, bukan dukungan di Rp115. Arus broker juga tidak mendukung akumulasi: foreign net +11,5 juta saham hari itu tetapi urutannya +71 juta, +53,8 juta, −80,8 juta, −30,2 juta; XL muncul sebagai top buy di average 118 sekaligus penjual besar (two-sided churn). Cluster akumulasi 116–120 berada di atas harga, jadi itu overhead supply, bukan support.

Keempat, sentimen bukan netral melainkan kosong: skor 5,0/10 adalah placeholder dari tiga sumber kosong dengan confidence rendah, dan SRSN.JK tidak muncul di top gainer/loser, top value, maupun news feed. Ketiadaan coverage pada microcap dengan turnover ~Rp4 miliar/hari, kapitalisasi Rp692 miliar, turnover 0,024, dan gap risk nyata (sudah pernah gap 124 → 106) justru menaikkan information risk dan slippage risk. Ini memperkuat alasan untuk mengecil, bukan menahan.

Arbitrase atas tiga ekstrem eksekusi: Konservatif benar bahwa menggantungkan seluruh exit pada rebound ke Rp120–126 adalah spekulasi dan bahwa residual 0,4–0,5x terlalu besar untuk nama selikuid ini; Netral benar bahwa menerima exit berapa pun harganya di bid tipis menciptakan slippage baru dan bahwa tranche bertahap dengan batas 10–15% turnover harian lebih realistis; Agresif benar bahwa tidak ada justifikasi untuk memperlakukan tape-only signal di Rp126 sebagai izin mengembalikan eksposur ke 0,75x. Karena itu saya mengambil posisi Sell dengan residual maksimum 0,25–0,35x (hard cap 0,4x), eksekusi bertahap, dan re-entry tape-only dibatasi 0,1–0,2x — bukan 0,75x.

Apa yang mengubah keputusan ini: (a) penutupan harian di atas Rp126 dengan volume di atas rata-rata 20 hari dan MACD histogram berbalik positif — itu mengubah narasi dari spekulasi menjadi konfirmasi tape, tetapi hanya cukup untuk posisi percobaan 0,1–0,2x; (b) verifikasi fundamental berupa operating cash flow yang mendukung laba H1, laporan Q3 2026 dengan margin bertahan di sekitar 28,9%/16,8%, balance sheet/net debt yang terverifikasi, atau insider buying baru di level harga sekarang — itu syarat untuk menaikkan ukuran melewati 0,5x. Sebaliknya, penutupan di bawah Rp106, penurunan tajam margin gross/operating di Q3 2026, atau insider selling skala besar memindahkan posisi ke exit penuh. Perlu dicatat eksplisit: laporan neraca, arus kas, dan data order flow multi-hari SRSN.JK tidak tersedia dalam materi ini, dan target harga fundamental tidak dapat diturunkan dari data yang ada — kekosongan itu diperlakukan sebagai alasan untuk tetap kecil, bukan sebagai sinyal positif maupun negatif.

Price Target: not provided

Time Horizon: 1-3 bulan (sampai laporan Q3 2026 atau verifikasi arus kas operasi)

Action: Sell

Reasoning: The proposed Underweight stance on SRSN.JK maps to Sell, not Hold. Price action is broken: lower highs at 150 → 132 → 126, the 16-Oct gap from 124 to 106, the failed 132 bounce, and a close at 115 below EMA10 120.26 and SMA20 126.10. MACD histogram is −1.98 and RSI 47.18 is not oversold, so the “oversold bounce” premise for SRSN.JK fails. Broker flow is noisy single-day churn, with buyers underwater at average 116–120, creating overhead supply rather than support. The bull case leans on annualized H1 profit and an implied 8x P/E without verified operating cash flow, YoY/seasonality/Q3 data, or fresh insider buying; insider purchases at Rp60–67 are stale and far below current price. Low leverage and above-SMA50/SMA200 support are not enough to offset unverified earnings quality and a broken daily structure. Do not initiate a fresh long in SRSN.JK; reduce existing exposure.

Entry Price: For existing SRSN.JK holders, use limit-sell orders into rebounds at Rp120–126; do not chase exits below Rp115. No fresh long at Rp115. No new short is recommended beyond the Sell/Underweight reduction.

Stop Loss: For any residual long in SRSN.JK, exit on a daily close below Rp106. Treat this as a close-only stop because it is only ~0.7 ATR (ATR Rp11.68) away and gap risk is real. Re-engagement trigger is a daily close above Rp126 with above-average volume and MACD histogram turning positive.

Position Sizing: Trim SRSN.JK to 0.4–0.5x standard allocation if currently at normal weight; if no position, hold 0%. Use 2–3 limit tranches and avoid executing more than ~10–15% of the ~Rp4bn daily turnover per session. Do not exceed 0.75x standard allocation even after re-entry triggers.

Recommendation: Underweight

Rationale: Saya menimbang kedua sisi dan kubu pesimis menang tipis-tapi-jelas, terutama karena seluruh jangkar tesis beli bergantung pada satu asumsi yang tidak bisa diverifikasi.

Yang memutuskan adalah tiga hal. Pertama, "P/E 8x" SRSN.JK bukan fakta, melainkan hasil annualisasi setengah tahun laba produsen ethanol/chemical yang marginnya sangat mungkin bersifat siklus spread feedstock. Bull tidak menyangkal tidak ada data YoY, seasonality, atau Q3 — dan tidak ada operating cash flow untuk membuktikan laba Rp43,16 miliar itu kas. Jadi margin of safety yang diklaim sebenarnya adalah margin of safety bersyarat. Kedua, struktur harga memang sudah rusak secara terukur: lower high 150 → 132 → 126, gap down 16 Oktober dari close 124 ke close 106, bounce 22 Oktober gagal di 132, harga di bawah EMA10 Rp120,26 dan SMA20 Rp126,10, MACD hist -1,98. Bull sendiri mengakui ini benar "untuk horizon harian" dan menawarkan close di atas Rp126 sebagai pembalik narasi — tetapi itu belum terjadi, jadi kita tidak boleh memposisikan diri seolah sudah. Ketiga, sinyal insider sudah basi: 14 pembelian di Rp60–67 terjadi 70–85% di bawah harga sekarang, dan tidak ada pembelian baru sekitar empat bulan. Itu bukti insentif di Rp60–67, bukan konfirmasi di Rp115. Ditambah overhead supply buyer broker di avg 116–120 yang sedang underwater, stop Rp106 yang hanya ~0,7 ATR, dan likuiditas ~Rp4 miliar/hari dengan risiko slippage saat exit.

Sisi bull tetap punya isi dan itu sebabnya saya tidak memilih Sell penuh. Beban bunga Rp0,54 miliar plus other income positif memberi indikasi leverage rendah; margin gross 28,9% / operasi 16,8% memang tidak biasa untuk produsen kecil; tidak ada insider selling besar; dan harga masih di atas SMA50 Rp110,60 serta SMA200 Rp75,90. Argumen "ketiadaan bukti akumulasi bukan bukti distribusi" itu valid. Tapi valuasi murah yang dibangun di atas laba yang belum terbukti berulang dan kas yang tidak terverifikasi adalah alasan untuk menahan diri, bukan alasan untuk menambah. Kubu bull menang di kualitas laba kertas, kubu bear menang di kualitas bukti — dan dalam debat ini bukti yang menang. Karena data neraca/arus kas benar-benar tidak tersedia, saya juga tidak mau membangun Sell penuh di atas ketiadaan data; itu simetris. Jadi: kurangi eksposur, jangan buka posisi baru, dan biarkan harga atau laporan Q3 yang membuktikan siapa benar.

Strategic Actions: 1) Sikap dasar: UNDERWEIGHT SRSN.JK terhadap alokasi standar. Jika portofolio saat ini memegang posisi seukuran alokasi normal, pangkas menjadi sekitar 0,4–0,5x alokasi standar. Jika belum ada posisi, jangan inisiasi pembelian baru di Rp115; tidak ada urgensi karena tesis bull belum terkonfirmasi harga maupun kas.

2. Eksekusi pemangkasan: gunakan limit order, jangan market order. Pecah menjadi 2–3 tranche, dan jangan mengeksekusi lebih dari ~10–15% dari nilai transaksi harian (sekitar Rp4 miliar) dalam satu sesi — dengan likuiditas sebesar itu, menjual terlalu cepat akan menggerakkan harga ke arah yang merugikan kita sendiri. Manfaatkan pantulan ke area Rp120–126 untuk menyelesaikan penjualan jika muncul; jangan menunggu Rp132.

3. Manajemen risiko untuk sisa posisi: batas rugi pada penutupan di bawah Rp106 (di bawah low 16 dan 19 Oktober). Perhatikan bahwa stop ini hanya ~0,7 ATR (ATR Rp11,68), jadi perlakukan sebagai level "keluar di close", bukan stop intraday, dan sadari risiko gap — saham ini sudah pernah gap 124 → 106.

4. Trigger untuk menaikkan kembali ke Hold/Overweight (harus terpenuhi minimal satu, idealnya dua): (a) penutupan di atas Rp126 dengan volume di atas rata-rata 20 hari dan MACD histogram berbalik positif — di situlah narasi bull berubah dari spekulasi menjadi konfirmasi; atau (b) bukti baru berupa operating cash flow yang mendukung laba H1 dan/atau filing pembelian insider di harga sekarang. Sebelum itu, tidak ada penambahan.

5. Trigger pembatalan tesis (pindah ke Sell): penutupan di bawah Rp106, atau laporan Q3 2026 yang menunjukkan margin gross/operasi turun tajam dari 28,9%/16,8%, atau munculnya laporan insider selling dalam skala besar.

6. Batas ukuran maksimum: meski trigger terpenuhi, jangan pernah melampaui 0,75x alokasi standar untuk SRSN.JK — kapitalisasi Rp692 miliar, turnover 0,024, dan ketiadaan balance sheet/arus kas yang terverifikasi berarti ini instrumen untuk ukuran kecil, bukan posisi inti.

7. Yang harus dicatat secara eksplisit ke trader: laporan neraca, arus kas, dan data order flow multi-hari SRSN.JK tidak tersedia dalam materi ini, serta skor sentimen 5,0 adalah placeholder tanpa artikel pendukung. Jangan memperlakukan kekosongan data itu sebagai sinyal positif maupun negatif — perlakukan sebagai alasan untuk tetap kecil.

SRSN (Indo Acidatama) — 27 Oct 2026 | Close Rp115 (−5.74%)

Verdict: AVOID as a new long. Holders should trim. This is a broken post-blowoff structure that is rolling over again, not an oversold bounce candidate. I reach the same "stay out" conclusion as the vendor, but not for its stated reason — the vendor calls SRSN "oversold," and the data says it isn't.

1. Where price actually is

Price is below EMA10 and below the SMA20/BB mid, and only ~4% above the SMA50 — the last structural line. It is still +51% above the SMA200, which tells you how far this ran and how much air is underneath.

2. The tape since the top is distribution, not basing

• Blowoff: 6 Oct high 150, close 143 on 5 Oct, on turnover Rp78.8bn and Rp55.6bn days. Peak volume was 3 Sep (1.00bn shares, Rp113tn) and 18 Sep (1.53bn shares, Rp200tn).
• 16 Oct: gapped down from a 124 close to a 106 open, closed 106 on the low (174.7m shares) — that is a decisive break, not noise.
• The bounce off 105 (19 Oct) topped out at 132 on 22 Oct and has already failed: 130 → 129 → 122 → 115. Lower highs are now 150 → 132 → 126.
• MACD has re-crossed down (hist −1.98) after a weak recovery attempt that stalled at 1.76 — a failed-recovery re-cross is a continuation signal, not a bottom.
• Volume is 144m vs a ~256m 20-day average (0.6x). Falling volume on a falling price after a blowoff is indifference, not capitulation — there is no evidence of a seller climax to buy.

3. Flow is two-sided churn, not accumulation

• Today: foreign net +11.5m shares (~8% of volume). But the sequence around it is +71m (12 Oct), +53.8m (16 Oct), −80.8m (20 Oct), −30.2m (23 Oct) — this is noise, not a campaign. There is no persistent bid.
• Broker summary: AK +Rp1.17bn, CC +Rp612m, YU +Rp449m vs XL (Stockbit) −Rp1.12bn, BK (JP Morgan) −Rp622m, PD −Rp541m. Note XL also appears as the top buy at avg 118 (Rp4.71bn) against Rp5.83bn sold — that is high-frequency two-sided churn, and it is the single largest counterparty.
• Critically, the accumulation price levels cluster at 116–120, i.e. above today's 115. The "heavy brokers" the vendor cites are underwater, which is supply overhead, not support.
• accumulation_history returned no rows and order_flow_detail returned zero ticks, so I cannot verify this is a multi-session campaign — I'm treating it as a single-day snapshot only.

4. Where I diverge from the vendor

5. Levels and plan

• Resistance: 122 (26 Oct close) → 126 (SMA20/BB mid) → 132 (22 Oct high). Nothing bullish until a close above 126 on expanding volume.
• Support: 114 (today's low) → 111 / 110.6 (S1 + SMA50) → 106 (16 & 19 Oct lows) → 103.7 (BB lower).
• Stop for anyone still long: below 110, i.e. a close under the SMA50. With ATR at 11.7, a 110 stop is only ~0.4 ATR away — too tight for this volatility, which is itself the argument for reducing rather than hoping.
• Trigger to re-engage: a daily close above 126 with volume back above the 20-day average and MACD hist turning positive. Until then, no entry.

6. Market context

Session 1, breadth mixed to soft: BBCA +3.06%, but BMRI −1.56%, BBRI −1.38%, TLKM −3.74%, BRPT −6.04%, ENRG −6.54%. Small caps are being hit harder than large caps — a poor backdrop for holding a high-beta name that is already below its 20-day mean.

Bottom line: the trend, the gap, the lower-high sequence and the re-crossing MACD all point the same way, while the only bullish inputs (foreign tick, brokerage snapshot) are noisy and located above the current price. Stand aside; do not average down.

SRSN.JK — Indo Acidatama Tbk (IDX)

Price: ~Rp 111–115 | Market cap: Rp 692bn | Shares out: 6.02bn

⚠️ Data availability caveat

The balance_sheet and cashflow tools returned only file-index stubs (no actual line items) across quarterly, annual, and multiple as-of dates — so P/B, net debt, working capital, and operating cash flow could not be verified. The income statement content came through embedded in the fundamentals payload. Seasonality tool returned no rows for SRSN. Conclusions below rest on the P&L, quote data, and insider activity only — treat as incomplete diligence.

H1 2026 P&L (period ended Jun-2026, Rp bn)

Valuation: H1 EPS ≈ Rp 7.17. Annualized EPS ≈ Rp 14.3 → ~7.7–8.0× P/E. Interest expense is trivial (0.2% of sales) and other income is positive, suggesting a low-leverage or net-cash balance sheet — but this is an inference, not verified.

Quality read: 28.9% gross / 16.8% operating margins are healthy for a commodity ethanol/acetic-acid producer, but this is inherently a thin-moat, spread-driven business — margins mean-revert with feedstock (molasses) and ethanol pricing cycles. One half-year of strong numbers is not a cycle average.

Insider activity — the most informative signal here

Ordered newest-first, the most recent record is 3 Jun 2026:

• Mulyadi Utomo Budhi Moeljono: relentless accumulation. 14 disclosed buys from 13 May → 3 Jun 2026, taking his stake from 102.47m → 165.51m shares (+63m, +61%) at Rp 60–67.
• Ludijanto Setijo: full exit. Sold 49.24m → 12 shares (essentially zero) at Rp 67–68 on 12–13 May 2026.

How to read this: The insider bought at Rp 60–67; the stock now trades at Rp 111–115. The signal was valid and has already paid out roughly +70–85% — it is now historical, not actionable. Critically, there have been no reported insider purchases in ~4 months while the price nearly doubled. An insider who bought 14 times in three weeks and then stops buying at 1.7× his entry is neutral-to-cautious, not a fresh confirmation. The one large seller liquidated at 67 — he left 65% on the table.

Assessment

Positives

• Cheap on earnings (~8× annualized), strong H1 margins, minimal interest burden.
• Insider cluster buying at the lows is genuine evidence of value recognition.
• Ethanol/industrial chemical demand in Indonesia is structurally supported (bioethanol blending mandates).

Negatives / risks

• Price is extended: +~70% off the May 2026 base; insider-buying catalyst is spent and unsupported at current levels.
• Illiquidity is severe: ~Rp 4.0bn daily value, turnover ratio 0.024 — 1,383 trades. Position sizing and exit slippage are real risks.
• No balance sheet or cash flow visibility. Cannot confirm whether H1 profit converted to cash, or the debt/working-capital position — critical for a commodity processor where receivables and inventory swings are large.
• No year-over-year revenue/profit comparison available, so growth and margin durability are unverified.
• No seasonality data for SRSN — no historical monthly edge to lean on.
• Micro-cap (Rp 692bn) with governance concentration; single-quarter tax rate of 22.1% is unremarkable but note "other income" of Rp 3.16bn is ~6% of pre-tax profit and may not recur.

Recommendation: HOLD — do not chase at Rp 111–115

• If you already own it (especially from the 60s–80s): hold, but trail a stop around Rp 95–100 to protect the gain. The ~8× P/E gives room, but the doubled price and absent insider support argue against adding.
• If you're flat: avoid initiating here. The edge was at Rp 60–67 alongside the insider; you'd now be buying 70% higher with no fresh catalyst and no balance-sheet data to underwrite the margin level. Wait for either (a) a pullback toward Rp 90–95 that holds, or (b) a new insider filing confirming buying at current prices.
• What would upgrade this to BUY: verified operating cash flow ≈ net income, net cash/no debt on the balance sheet, and Q3 2026 margins holding near 28%/17% gross/operating. Any of those failing — or Q3 margins compressing on molasses/feedstock costs — would make this a pass regardless of the headline P/E.

Confidence: low-to-moderate, constrained by the missing balance sheet, cash flow, and prior-year comparatives. I'd re-run this once statement data is retrievable.

Overall Sentiment: Neutral (Score: 5.0/10) Confidence: Low

Sentiment Report — SRSN.JK (PT Indo Acidatama Tbk)

⚠️ Data Availability Notice (read first)

No sentiment data was returned for SRSN.JK in this run. All three source channels — news/financial media, retail social/forum discussion, and broker/analyst commentary — came back empty. No article counts, post counts, ratios, or notable messages exist to cite. Everything below is therefore flagged accordingly, and the 5.0 / Neutral reading is a placeholder for genuine silence, not a measured mid-point between bulls and bears. Do not treat the score as evidence of balanced opinion.

1. Source-by-Source Breakdown

There is genuinely nothing to ratio, quote, or characterise. I will not synthesise plausible-sounding message counts or paraphrase posts that do not exist.

2. Cross-Source Divergences and Alignments

There are no divergences to report because there are no readings — three independent silences are not three agreeing signals. The most important structural observation is why the silence is likely occurring:

• Micro-cap / illiquid profile. SRSN.JK is a small-capacity Indonesian basic-materials name (ethanol and acetic-acid-adjacent industrial chemicals) with a modest free float and thin average daily turnover. Names of this profile are systematically under-covered by both the English-language news wires and the retail forum ecosystem that most sentiment pipelines index.
• Language and venue mismatch. The substantive discussion that does exist for Indonesian small caps typically sits in Bahasa Indonesia on local platforms (local broker research portals, IDX-centric forums, Stockbit-style communities), which are frequently outside the retrieval footprint of standard sentiment feeds. A null result here is therefore more likely a coverage gap than a genuine absence of opinion.
• No scheduled catalyst in window. Small chemical producers generate news flow almost exclusively around quarterly earnings, dividend announcements, or feedstock/margin shocks. Outside those windows, the tape is quiet by construction.

3. Dominant Narrative Themes

None identified from data. I will not manufacture themes. The only defensible statement is that no narrative is currently circulating in the venues surveyed — which for a name this size should be read as "no coverage," not "no controversy."

4. Catalysts and Risks the Data Would Need to Speak To

Because sentiment is unmeasured, I have no data-derived catalysts to surface. Below are the questions a follow-up run should be pointed at, stated as watch-items rather than as sentiment findings:

• Feedstock and input-cost exposure — molasses/ethanol input economics are the dominant margin driver for this business; any move in agricultural input prices is a first-order sentiment trigger for Indonesian chemical producers.
• Quarterly earnings and dividend cadence — for thin-coverage small caps, a single results release can reset the entire information set; sentiment snapshots taken mid-quarter carry almost no signal.
• Liquidity-driven price noise — in a name with low turnover, small absolute flows produce outsized percentage moves. Any sentiment signal derived from price action alone would be spurious here and should not be mistaken for conviction.
• Currency and policy sensitivity — IDR volatility and domestic industrial/energy policy affect both input costs and end-market demand.
• Governance and disclosure quality — small-cap Indonesian issuers vary widely in disclosure frequency; low disclosure mechanically suppresses news flow and therefore mechanically suppresses measured sentiment.

5. Summary of Sentiment Signals

Bottom Line for the Trader

Treat this as a no-signal reading, not a neutral verdict. The correct inference is that SRSN.JK is outside the coverage footprint of the surveyed channels — most likely a liquidity/size/language artefact rather than an absence of risk or opportunity. Any position decision on this name needs to rest on fundamental work (filings, feedstock economics, liquidity profile), not on this report. A re-run targeted at Bahasa-language local sources and IDX-specific disclosure channels would be required before sentiment could contribute anything at all.

SRSN.JK — Findings

Bottom line: there is no actionable signal here, and very little data. I can't build a real view on this name from what's available.

What the tools actually returned

1. Not in today's screener. The run (V5.2, stamped Tuesday 27 Oct 2026, fresh) flagged only three names — PIPA, BLES, IMPC. SRSN didn't trigger any technical + broker-accumulation signal. Absence from a shortlist of three isn't bearish, but it means the one systematic edge the vendor offers doesn't apply.

2. No footprint in today's tape. With ~800–824 stocks trading, SRSN appears in none of the ranked lists:

• Not a top-10 gainer or top-10 loser
• Not in the top-10 by traded value (that list is led by BBCA Rp747bn, BMRI, TLKM, BBRI, BUMI)

A micro-cap posting no rank on any of these is normal — it just means nothing unusual is happening in it today.

3. Zero news coverage. get_news returned DATA_UNAVAILABLE across both FY2025 and the recent Aug–Oct 2026 window — Yahoo has no articles tagged SRSN.JK at all. For contrast, the global feed is working fine (10 items, IBM/Cisco/news-heavy). So this is a coverage gap on the ticker, not a vendor outage. For a small-cap steel sheet maker, that's typical but it does mean there's no public catalyst to read and no verification path — I won't infer anything from silence.

4. Market context is mildly risk-off in the heavyweights. Sesi 1 open, breadth mixed: BBCA +3.06% and ANTM +1.8% green, but TLKM −3.74%, BMRI −1.56%, BBRI −1.38%, ENRG −6.54%, BRPT −6.04%. Big-cap money is rotating, not broadly buying. That's a poor backdrop for illiquid small caps to attract flow.

Why I'm not giving you a call

For SRSN specifically I have no price, no volume, no financials, no broker summary, no news. Every quantitative input that would justify a buy/sell/hold is missing. Anything I said about direction would be invented. Two things you'd want before acting, neither of which I can retrieve here:

• Liquidity check — daily value traded and bid/ask depth. On names this thin the spread alone can eat the entire expected return.
• The actual filings — recent quarterly report, any going-concern or debt-covenant disclosure, and shareholder structure. Micro-cap steel in Indonesia has historically been a sector where balance-sheet stress, not chart patterns, drives outcomes.

One flag on the data itself: the screener and breadth endpoints both timestamp 27 October 2026, well past my assumed date. If that's a vendor clock error, treat the freshness label with suspicion. If it's genuine, my earlier news window was wrong and I've since re-queried to match — still nothing.

Want me to look at a comparable that does have coverage, or re-run the screener/breadth later in the session to see if SRSN shows up on the volume or frequency ranking?